Neurologists are highly trained medical professionals who play a critical role in the healthcare system in helping patients of all ages manage their conditions that can affect every aspect of their lives. Each month, NeurologyLive® shines a spotlight on the work of one neurologist, highlighting contributions to their specific field.
There is a well-known shortage of neurologists relative to the number of patients with neurological disorders. This shortage disproportionately affects Black and Hispanic individuals, leading to significant disparities in access to care and clinical outcomes. For patients with multiple sclerosis (MS), timely access to a comprehensive multidisciplinary team and early disease-modifying treatments is crucial for improving long-term prognosis.
A team of researchers, led by Marisa McGinley, DO, recently published a cross-sectional analysis on geographic access to neurologists and MS centers across US census tracts.1 The study utilized Medicare data to determine neurologist locations, the 2020 American Community Survey 5-year estimates, the 2010 rural-urban commuting area codes, and MS center locations as defined by the Consortium of Multiple Sclerosis Centers. This comprehensive approach aimed to assess geospatial access to neurologists and MS centers, while also examining demographic and community characteristics related to this access.
Out of 70,858 census tracts, 388 had no neurologists within a 60-minute drive, and 17,837 had no MS centers within 60 miles. Geographic access to neurologists was significantly lower in rural areas (–80.49%; 95% CI, –81.65 to –79.30) and micropolitan areas (–60.50%; 95% CI, –62.40 to –58.51) compared with metropolitan areas. In addition, census tracts with a higher proportion of underrepresented minorities, uninsured people, and disabled individuals experienced the lowest access to neurologists.
More recently, McGinley, a staff neurologist from the Mellen Center for MS Treatment and Research at the Cleveland Clinic, had a conversation with NeurologyLive to discuss what motivated her as a neurologist to specialize in treating MS. She also talked about some of the primary challenges in the field of MS care according to her clinical perspective. Furthermore, McGinley talked about how she balances patient care with research responsibilities as a neurologist and expressed her passion for improving access to neurological care.
Clinical Facts About Multiple Sclerosis
- A total of 2.8 million patients are estimated to live with multiple sclerosis (MS) worldwide and women are twice as likely to live with MS than men.
- The prevalence of MS has increased in every world region since 2013 but gaps in prevalence estimates persist.
- The pooled incidence rate across 75 reporting countries is 2.1 per 100,000 persons/year, and the mean age of diagnosis is 32 years.
REFERENCES
1. Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816-1821. doi:10.1177/1352458520970841
NeurologyLive: What are some of the main responsibilities you have in your role as a neurologist?
As a neurologist, my main role is to care for patients with neurological conditions. I primarily treat patients with MS and related conditions including neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). In my role, I care for patients across the spectrum of their condition from diagnosis and throughout their lifetime. It is a privilege to develop long-lasting relationships with patients. In this role, my goal is to provide holistic care for patients that include diagnosis, treatment with disease-modifying therapies, monitoring, symptomatic care, and referral to multidisciplinary rehabilitation and other specialists. Another significant portion of my job focuses on research aimed at improving access to neurological care.
Could you describe a typical day in your work as a neurologist?
As a neurologist, I see patients in the office along the continuum of the MS journey. My days include a mix of seeing new patients with a concern for a new MS diagnosis and patients who have an established diagnosis for many years. In addition to my patient care, I also engage in research, which includes working with other researchers and seeing patients for clinical trials.
What motivated you to pursue a career in neurology, and when did you make this decision?
I have always wanted to be a doctor, but my strong interest in neurology started when I was in college. I had a family member diagnosed with MS, which exposed me to the very important role that the neurologist plays in the diagnosis and management of a lifelong condition. I saw how terrifying receiving an MS diagnosis in your 20’s can be for the patient and also the family. There is so much uncertainty about the long-term effects and how someone will respond to treatment. It was this experience that made me passionate about being part of this journey for patients. I really value the long-term relationship with these patients and the potential to make a significant difference through the use of current treatments, but also the potential to make an impact on future treatment options and care models.